New phase 3, randomized, double-blind clinical trial was conducted to know the safety and efficacy of teriflunomide, an oral immunomodulatory drug approved for the treatment of adults with relapsing multiple sclerosis.
from Medindia Health News https://ift.tt/3lpnoaB
No comments:
Post a Comment